| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $127.2M | — | +55.6% |
| Cost of Revenue | $1.9M | — | -58.3% |
| R&D Expense | $57.1M | — | +21.8% |
| SG&A Expense | $80.3M | — | +10.2% |
| Operating Income | -$36.9M | — | +13.5% |
| Pre-tax Income | -$36.7M | — | +10.8% |
| Income Tax | -$120K | — | -407.7% |
| Net Income | -$37.1M | — | +10.0% |
| EPS (Basic) | -$0.40 | — | +14.9% |
| EPS (Diluted) | -$0.40 | — | +14.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $78.4M | -15.8% | +26.6% |
| Accounts Receivable | $87.3M | +8.9% | +153.9% |
| Inventory | $37.1M | +2.5% | -2.5% |
| Current Assets | $392.7M | -10.3% | +4.9% |
| Total Assets | $555.2M | -8.3% | +1.2% |
| Current Liabilities | $125.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.4M | — | +4.3% |
| Investing Cash Flow | $21.5M | — | -47.8% |
| Financing Cash Flow | $4.2M | — | +13.1% |
| -31.3% |
| Total Liabilities | $456.5M | -6.9% | -11.5% |
| Stockholders' Equity | $98.7M | -14.0% | +200.8% |